世界のPOC分析装置市場:医療機器パイプライン分析2016

◆英語タイトル:Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0212EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年7月4日
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,368,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、POC分析装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・POC分析装置の概要
・POC分析装置の開発動向:開発段階別分析
・POC分析装置の開発動向:セグメント別分析
・POC分析装置の開発動向:領域別分析
・POC分析装置の開発動向:規制Path別分析
・POC分析装置の開発動向:承認日(推定)別分析
・企業別POC分析装置の開発動向(パイプライン製品、進行中の治験)
・POC分析装置の最近動向
【レポートの概要】

Point-of-Care (POC) Analyzers – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Point-of-Care (POC) Analyzers – Medical Devices Pipeline Assessment, 2016″ provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Point-of-Care (POC) Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Point-of-Care (POC) Analyzers Overview 7
3 Products under Development 8
3.1 Point-of-Care (POC) Analyzers – Pipeline Products by Stage of Development 8
3.2 Point-of-Care (POC) Analyzers – Pipeline Products by Territory 9
3.3 Point-of-Care (POC) Analyzers – Pipeline Products by Regulatory Path 10
3.4 Point-of-Care (POC) Analyzers – Pipeline Products by Estimated Approval Date 11
4 Point-of-Care (POC) Analyzers – Pipeline Products under Development by Companies 12
4.1 Point-of-Care (POC) Analyzers Companies – Pipeline Products by Stage of Development 12
4.2 Point-of-Care (POC) Analyzers – Pipeline Products by Stage of Development 14
5 Point-of-Care (POC) Analyzers Companies and Product Overview 16
5.1 Akers Biosciences, Inc. Company Overview 16
5.1.1 Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Akonni Biosystems, Inc. Company Overview 18
5.2.1 Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 ApoCell, Inc. Company Overview 19
5.3.1 ApoCell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Attophotonics Biosciences GmbH Company Overview 20
5.4.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Bio-Alternative Medical Devices Ltd Company Overview 21
5.5.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 BioDirection, Inc. Company Overview 23
5.6.1 BioDirection, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 BioMedomics, Inc Company Overview 24
5.7.1 BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 bioMerieux S.A. Company Overview 26
5.8.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Biopico Systems Inc. Company Overview 28
5.9.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 Boston University Company Overview 29
5.10.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Cepheid Company Overview 31
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Co-Diagnostics HBDC, Inc. Company Overview 34
5.12.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Indian Institute of Technology, Madras Company Overview 35
5.13.1 Indian Institute of Technology, Madras Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 John Hopkins University Company Overview 36
5.14.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Magna Diagnostics GmbH Company Overview 38
5.15.1 Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
5.16 McKesson Corporation Company Overview 39
5.16.1 McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview 39
5.17 Nanomix, Inc. Company Overview 41
5.17.1 Nanomix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 OncoGenesis Company Overview 42
5.18.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 Phoenix Biosystems Inc Company Overview 43
5.19.1 Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.20 PositiveID Corporation Company Overview 44
5.20.1 PositiveID Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.21 Quanterix Corporation Company Overview 46
5.21.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Radisens Diagnostics Limited Company Overview 48
5.22.1 Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 Rapid Biosensor Systems Company Overview 50
5.23.1 Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 SenGenix, Inc. Company Overview 51
5.24.1 SenGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Thermal Gradient, Inc. Company Overview 52
5.25.1 Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.26 University of Alberta Company Overview 54
5.26.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 54
5.27 University of California, Berkeley Company Overview 55
5.27.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 55
5.28 University of California, Davis Company Overview 57
5.28.1 University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview 57
5.29 Wellstat Diagnostics, LLC Company Overview 58
5.29.1 Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.30 Xen Biofluidx Inc Company Overview 59
5.30.1 Xen Biofluidx Inc Pipeline Products & Ongoing Clinical Trials Overview 59
6 Point-of-Care (POC) Analyzers- Recent Developments 60
6.1 Jun 29, 2016: McKesson Updates Fiscal 2017 Guidance 60
6.2 May 25, 2016: Thermal Gradient Performs 13 Minute MRSA Test 60
6.3 Dec 03, 2015: Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 60
7 Appendix 61
7.1 Methodology 61
7.2 About GlobalData 63
7.3 Contact Us 64
7.4 Disclaimer 64

1.1 List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 8
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 9
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 10
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 11
Table 5: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 12
Table 6: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 14
Table 7: Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 8: minDNAnalyzer - Product Status 16
Table 9: minDNAnalyzer - Product Description 17
Table 10: Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 11: Point-Of-Care Device - Tuberculosis - Product Status 18
Table 12: Point-Of-Care Device - Tuberculosis - Product Description 18
Table 13: ApoCell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 14: ApoStream System - Product Status 19
Table 15: ApoStream System - Product Description 19
Table 16: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 20
Table 17: Nanoparticle Microfluidic Color Device - Product Status 20
Table 18: Nanoparticle Microfluidic Color Device - Product Description 20
Table 19: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
Table 20: Magnetic Immunoassay Detection System - Product Status 21
Table 21: Magnetic Immunoassay Detection System - Product Description 22
Table 22: BioDirection, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 23: Tbit Hand-held System - Product Status 23
Table 24: Tbit Hand-held System - Product Description 23
Table 25: BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 26: Next Generation Ultra-sensitive Nanotube Platform - Product Status 24
Table 27: Next Generation Ultra-sensitive Nanotube Platform - Product Description 25
Table 28: TR-LFIA Diagnostic Platform - Product Status 25
Table 29: TR-LFIA Diagnostic Platform - Product Description 25
Table 30: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Magnotech System - Product Status 26
Table 32: Magnotech System - Product Description 27
Table 33: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: MONITOR System - Product Status 28
Table 35: MONITOR System - Product Description 28
Table 36: Boston University Pipeline Products & Ongoing Clinical Trials Overview 29
Table 37: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status 29
Table 38: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description 30
Table 39: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 31
Table 40: GeneXpert Omni - Product Status 31
Table 41: GeneXpert Omni - Product Description 32
Table 42: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 32
Table 43: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 33
Table 44: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 45: LightPCR - Product Status 34
Table 46: LightPCR - Product Description 34
Table 47: Indian Institute of Technology, Madras Pipeline Products & Ongoing Clinical Trials Overview 35
Table 48: Microfluidic Flow Analyzer - Product Status 35
Table 49: Microfluidic Flow Analyzer - Product Description 35
Table 50: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 51: Point-Of-Care Sensor - Brain Injury - Product Status 36
Table 52: Point-Of-Care Sensor - Brain Injury - Product Description 37
Table 53: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
Table 54: MAZER System - Product Status 38
Table 55: MAZER System - Product Description 38
Table 56: McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview 39
Table 57: Proventys PDx System - Product Status 39
Table 58: Proventys PDx System - Product Description 40
Table 59: Nanomix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 60: Nanomix System - Ebola Virus - Product Status 41
Table 61: Nanomix System - Ebola Virus - Product Description 41
Table 62: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 42
Table 63: Genesis Point-Of-Care Diagnostic System - Product Status 42
Table 64: Genesis Point-Of-Care Diagnostic System - Product Description 42
Table 65: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 66: Point of Care HIV Combo Device - Product Status 43
Table 67: Point of Care HIV Combo Device - Product Description 43
Table 68: PositiveID Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
Table 69: Firefly Dx System - Zika Virus - Product Status 44
Table 70: Firefly Dx System - Zika Virus - Product Description 45
Table 71: Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
Table 72: POC Device - Neurological Injuries - Product Status 46
Table 73: POC Device - Neurological Injuries - Product Description 46
Table 74: Simoa 5.0 - Product Status 47
Table 75: Simoa 5.0 - Product Description 47
Table 76: Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 48
Table 77: Radisens Instrument - Product Status 48
Table 78: Radisens Instrument - Product Description 49
Table 79: Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview 50
Table 80: Rapid Test Device - Malaria - Product Status 50
Table 81: Rapid Test Device - Malaria - Product Description 50
Table 82: SenGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 83: SenGenix Strips And Reader System - Product Status 51
Table 84: SenGenix Strips And Reader System - Product Description 51
Table 85: Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 86: FlashDirect-HC - Product Status 52
Table 87: FlashDirect-HC - Product Description 53
Table 88: FlashDirect-LC - Product Status 53
Table 89: FlashDirect-LC - Product Description 53
Table 90: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 54
Table 91: POC Device - Zika Virus - Product Status 54
Table 92: POC Device - Zika Virus - Product Description 54
Table 93: University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 55
Table 94: Microfluidic Blotting Device - Product Status 55
Table 95: Microfluidic Blotting Device - Product Description 55
Table 96: Multi-dimensional Microfluidic Device - Product Status 56
Table 97: Multi-dimensional Microfluidic Device - Product Description 56
Table 98: University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview 57
Table 99: Blood Safety Microchip - Product Status 57
Table 100: Blood Safety Microchip - Product Description 57
Table 101: Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
Table 102: Electrochemiluminescent Based RNA Detection Platform - Product Status 58
Table 103: Electrochemiluminescent Based RNA Detection Platform - Product Description 58
Table 104: Xen Biofluidx Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 105: Xen System - Product Status 59
Table 106: Xen System - Product Description 59
Table 107: Glossary 62

1.2 List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 8
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 9
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 10
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 11

【掲載企業】

Akers Biosciences, Inc.
Akonni Biosystems, Inc.
ApoCell, Inc.
Attophotonics Biosciences GmbH
Bio-Alternative Medical Devices Ltd
BioDirection, Inc.
BioMedomics, Inc
bioMerieux S.A.
Biopico Systems Inc.
Boston University
Cepheid
Co-Diagnostics HBDC, Inc.
Indian Institute of Technology, Madras
John Hopkins University
Magna Diagnostics GmbH
McKesson Corporation
Nanomix, Inc.
OncoGenesis
Phoenix Biosystems Inc
PositiveID Corporation
Quanterix Corporation
Radisens Diagnostics Limited
Rapid Biosensor Systems
SenGenix, Inc.
Thermal Gradient, Inc.
University of Alberta
University of California, Berkeley
University of California, Davis
Wellstat Diagnostics, LLC
Xen Biofluidx Inc

★調査レポート[世界のPOC分析装置市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界のPOC分析装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆